Join Growin Stock Community!

Beyondspring inc.BYSI.US Overview

US StockHealthcare
(No presentation for BYSI)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

BYSI AI Insights

BYSI Overall Performance

BYSI AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

BYSI Recent Performance

-0.74%

Beyondspring inc.

0.05%

Avg of Sector

-0.31%

S&P500

BYSI PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

BYSI Key Information

BYSI Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

BYSI Profile

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.

Price of BYSI

BYSI FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

BYSI Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.01
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
31.22
PB Ratio
5.38
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
100.00%
Net Margin
119.00%
Revenue Growth (YoY)
-100.00%
Profit Growth (YoY)
-100.00%
3-Year Revenue Growth
-100.00%
3-Year Profit Growth
-100.00%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.01
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
31.22
PB Ratio
5.38
Price-to-FCF
-
Gross Margin
100.00%
Net Margin
119.00%
Revenue Growth (YoY)
-100.00%
Profit Growth (YoY)
-100.00%
3-Year Revenue Growth
-100.00%
3-Year Profit Growth
-100.00%

  • When is BYSI's latest earnings report released?

    The most recent financial report for Beyondspring inc. (BYSI) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating BYSI's short-term business performance and financial health. For the latest updates on BYSI's earnings releases, visit this page regularly.

  • How is BYSI's revenue growth?

    In the latest financial report, Beyondspring inc. (BYSI) announced revenue of 0, with a Year-Over-Year growth rate of 100%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does BYSI have?

    As of the end of the reporting period, Beyondspring inc. (BYSI) had total debt of 406K, with a debt ratio of 0.01. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does BYSI have?

    At the end of the period, Beyondspring inc. (BYSI) held Total Cash and Cash Equivalents of 12.48M, accounting for 0.42 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Is BYSI's EPS continuing to grow?

    According to the past four quarterly reports, Beyondspring inc. (BYSI)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.04. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.